Prospective population-based study on the survival of patients with lung cancer Source: Eur Respir J 2002; 19: 1087-1092 Year: 2002
Validation and comparison of several published prognostic systems for patients with small cell lung cancer Source: Eur Respir J 2011; 38: 657-663 Year: 2011
Determinants of the performance status in stage IV nonsmall cell lung cancer - results of a population-based study Source: Eur Respir J 2001; 18: Suppl. 33, 230s Year: 2001
A new TNM classification is better than ISS at predicting survival in stage III unresectable non-small cell lung cancer (NSCLC). A study by the European lung cancer working party (ELCWP) Source: Eur Respir J 2003; 22: Suppl. 45, 163s Year: 2003
Small cell lung cancer (SCLC) in Norway. A population-based study Source: Annual Congress 2008 - Actual challenges in thoracic surgery Year: 2008
Staging of lung cancer Source: Eur Respir Mon; 2009: 44: 150–168 Year: 2009
Survival depends on the site of distant metastases in nonsmall cell lung cancer - results of a population based study Source: Eur Respir J 2001; 18: Suppl. 33, 230s Year: 2001
A proposal in small cell lung cancer staging according to TNM system Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer Year: 2012
Predictors of radiation-induced lung toxicity in patients with locally advanced non small cell lung cancer (NSCLC): a retrospective analysis Source: Annual Congress 2009 - Management of thoracic malignancies Year: 2009
Lung cancer survival in the UK: are the results from the national lung cancer audit (LUCADA) dependent on completeness of case reporting? Source: Annual Congress 2009 - Epidemiology and management of lung cancer Year: 2009
Relevance of clinical TNM-staging in small cell lung cancer (SCLC) for survival – A retrospective case study in 633 patients Source: Annual Congress 2010 - Staging of lung cancer Year: 2010
Staging with FDG-PET/CT influences stage-specific survival in non small cell lung cancer (NSCLC) Source: Annual Congress 2011 - Imaging in oncology and infectious diseases Year: 2011
Prognostic value of mean platelet volume in non-small cell lung cancer: a real-world, registry-based study Source: International Congress 2019 – Early detection, follow-up and epidemiology of lung cancer Year: 2019
COX-2 as prognostic factor in lung cancer: systematic review of the literature with meta-analysis Source: Annual Congress 2005 - Prognostic factors in lung cancer Year: 2005
Biological factors predicting response to chemotherapy (CT) in advanced non small cell lung cancer (NSCLC): A feasibility study on the collection of tissue Source: Annual Congress 2010 - The role of biomarkers in lung cancer Year: 2010
Tumour growth rate as a tool for response evaluation during PD-1 treatment for non-small cell lung cancer: a retrospective analysis Source: ERJ Open Res, 5 (4) 00179-2019; 10.1183/23120541.00179-2019 Year: 2019
Gender and survival in lung cancer (LC): results of a healthcare study in WestGermany Source: Eur Respir J 2001; 18: Suppl. 33, 229s Year: 2001
Overall survival analysis and characterization of an EGFR mutated non small cell lung cancer (NSCLC) population Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up Year: 2017
Quality indicators in lung cancer care-review of resection rates in early stage NSCLC (non small cell lung cancer) at King’s Source: International Congress 2018 – Lung cancer: risk factors, supportive measures and quality improvement Year: 2018